1. Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer
   Evangelia Papadimitriou et al, 2016, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. Noncanonical agonist PPARγ ligands modulate the response to DNA damage and sensitize cancer cells to cytotoxic chemotherapy
   Melin J. Khandekar et al, 2018, Proc Natl Acad Sci USA CrossRef
3. Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells
   Peng Huang et al, 2018, Cell Commun Signal CrossRef
4. null
   Xu Wang, 2020 CrossRef
5. Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
   Dapeng Wu et al, 2017, Oncotarget CrossRef
6. The hispanic landscape of triple negative breast cancer
   Alejandra Zevallos et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
7. The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs
   Eman Sami et al, 2021, Cancer Gene Ther CrossRef
8. Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
   Sepideh Mirzaei et al, 2021, Drug Discovery Today CrossRef
9. Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis
   Evangelia Papadimitriou et al, 2023, IJMS CrossRef
10. Multimodal AI for prediction of distant metastasis in carcinoma patients
    Isaac Olatunji et al, 2023, Front. Bioinform. CrossRef